Tissue Array
Log In | My Account | Cart (0 items) - $0.00
US Biomax, Inc.
 

ES962

Esophageal squamous cell carcinoma tissue array, including TNM, clinical stage and pathology grade, 48 cases/96 cores
Unstained: $215.00 Add to Cart
H&E (ES962s*): $215.00 Add to Cart

Microarray Panel:Esophagus cancer tissue microarray, containing 36 cases of esophageal squamous cell carcinoma, 2 esophageal carcinoma in situ, 5 esophageal chronic inflammation，1 esophageal atypical hyperplasia, plus 4 normal esophageal tissue, duplicate cores per case (duplicated cores from the same patient were put onto upper and lower rows in the same positions.)
Cores:96
Cases:48
Layout:12 cols × 8 rows
Core Diameter:1.5 mm
Thickness:5 µm
Quality Control:Anti-Actin confirmed
Applications:Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.
Notes:Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure.

*Tissue Microarray Slide Types:

  • Unstained: unstained paraffin tissue microarray slide.
  • Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
  • H & E: Hematoxylin and Eosin stained tissue microarray slide.

Microarray Panel Display

 
Slide Label: US Biomax, Inc. Tissue Array
123456789101112 
A Eso Eso Eso Eso Eso Eso Eso Eso Eso Eso Eso Eso  
B Eso Eso Eso Eso Eso Eso Eso Eso Eso Eso Eso Eso  
C Eso Eso Eso Eso Eso Eso Eso Eso Eso Eso Eso Eso  
D Eso Eso Eso Eso Eso Eso Eso Eso Eso Eso Eso Eso  
E Eso Eso Eso Eso Eso Eso Eso Eso Eso Eso Eso Eso  
F Eso Eso Eso Eso Eso Eso Eso Eso Eso Eso Eso Eso  
G Eso Eso Eso Eso Eso Eso Eso Eso Eso Eso Eso Eso  
H Eso Eso Eso Eso Eso Eso Eso Eso Eso Eso Eso Eso Marked point
Legend: Eso - Esophagus

- Hyperplasia, - , - Inflammation, - Malignant tumor, - Malignant tumor (stage III), - Malignant tumor (stage IIa), - Normal tissue

Specification Sheet

Pos No. Sex Age Organ Pathology diagnosis Grade Stage TNM Type †
A1 1 M 56 Esophagus Squamous cell carcinoma 1 IIa T3N0M0 Malignant
A2 2 M 48 Esophagus Squamous cell carcinoma 1 III T3N1M0 Malignant
A3 3 M 61 Esophagus Squamous cell carcinoma 1 IIa T3N0M0 Malignant
A4 4 M 59 Esophagus Squamous cell carcinoma 1 IIa T3N0M0 Malignant
A5 5 M 51 Esophagus Squamous cell carcinoma 1 IIa T3N0M0 Malignant
A6 6 M 71 Esophagus Squamous cell carcinoma 2 IIa T3N0M0 Malignant
A7 7 M 56 Esophagus Squamous cell carcinoma 1 IIa T2N0M0 Malignant
A8 8 M 59 Esophagus Squamous cell carcinoma (sparse) 1 IIa T2N0M0 Malignant
A9 9 M 62 Esophagus Squamous cell carcinoma 1 IIa T2N0M0 Malignant
A10 10 F 71 Esophagus Squamous cell carcinoma 1 IIa T2N0M0 Malignant
A11 11 M 67 Esophagus Squamous cell carcinoma 1 IIa T2N0M0 Malignant
A12 12 M 74 Esophagus Squamous cell carcinoma 2 IIa T3N0M0 Malignant
B1 13 M 56 Esophagus Squamous cell carcinoma 1 IIa T3N0M0 Malignant
B2 14 M 48 Esophagus Squamous cell carcinoma 1 III T3N1M0 Malignant
B3 15 M 61 Esophagus Squamous cell carcinoma 1 IIa T3N0M0 Malignant
B4 16 M 59 Esophagus Squamous cell carcinoma 1 IIa T3N0M0 Malignant
B5 17 M 51 Esophagus Squamous cell carcinoma 1 IIa T3N0M0 Malignant
B6 18 M 71 Esophagus Squamous cell carcinoma 2 IIa T3N0M0 Malignant
B7 19 M 56 Esophagus Squamous cell carcinoma 1 IIa T2N0M0 Malignant
B8 20 M 59 Esophagus Squamous cell carcinoma 1 IIa T2N0M0 Malignant
B9 21 M 62 Esophagus Squamous cell carcinoma 1 IIa T2N0M0 Malignant
B10 22 F 71 Esophagus Squamous cell carcinoma 1 IIa T2N0M0 Malignant
B11 23 M 67 Esophagus Squamous cell carcinoma 1 IIa T2N0M0 Malignant
B12 24 M 74 Esophagus Squamous cell carcinoma 2 IIa T3N0M0 Malignant
C1 25 F 53 Esophagus Squamous cell carcinoma 2 IIa T2N0M0 Malignant
C2 26 F 72 Esophagus Squamous cell carcinoma 2 IIa T3N0M0 Malignant
C3 27 M 67 Esophagus Squamous cell carcinoma 2 IIa T3N0M0 Malignant
C4 28 M 62 Esophagus Squamous cell carcinoma 2 IIa T2N0M0 Malignant
C5 29 F 40 Esophagus Squamous cell carcinoma 2 IIa T2N0M0 Malignant
C6 30 M 53 Esophagus Squamous cell carcinoma 2 IIa T3N0M0 Malignant
C7 31 M 66 Esophagus Squamous cell carcinoma 1 IIa T2N0M0 Malignant
C8 32 F 60 Esophagus Squamous cell carcinoma 1 IIa T3N0M0 Malignant
C9 33 F 52 Esophagus Squamous cell carcinoma 2 IIa T3N0M0 Malignant
C10 34 F 69 Esophagus Squamous cell carcinoma 2 IIa T3N0M0 Malignant
C11 35 M 62 Esophagus Squamous cell carcinoma 2 IIa T2N0M0 Malignant
C12 36 F 46 Esophagus Squamous cell carcinoma 2 IIa T2N0M0 Malignant
D1 37 F 53 Esophagus Squamous cell carcinoma 2 IIa T2N0M0 Malignant
D2 38 F 72 Esophagus Squamous cell carcinoma 2 IIa T3N0M0 Malignant
D3 39 M 67 Esophagus Squamous cell carcinoma 2 IIa T3N0M0 Malignant
D4 40 M 62 Esophagus Squamous cell carcinoma 2 IIa T2N0M0 Malignant
D5 41 F 40 Esophagus Squamous cell carcinoma 2 IIa T2N0M0 Malignant
D6 42 M 53 Esophagus Squamous cell carcinoma 2 IIa T3N0M0 Malignant
D7 43 M 66 Esophagus Squamous cell carcinoma 1 IIa T2N0M0 Malignant
D8 44 F 60 Esophagus Squamous cell carcinoma 1 IIa T3N0M0 Malignant
D9 45 F 52 Esophagus Squamous cell carcinoma 2 IIa T3N0M0 Malignant
D10 46 F 69 Esophagus Squamous cell carcinoma 2 IIa T3N0M0 Malignant
D11 47 M 62 Esophagus Squamous cell carcinoma 2 IIa T2N0M0 Malignant
D12 48 F 46 Esophagus Squamous cell carcinoma 2 IIa T2N0M0 Malignant
E1 49 M 60 Esophagus Squamous cell carcinoma 2 IIa T3N0M0 Malignant
E2 50 M 59 Esophagus Squamous cell carcinoma 2 IIa T3N0M0 Malignant
E3 51 F 47 Esophagus Squamous cell carcinoma 2 IIa T3N0M0 Malignant
E4 52 M 60 Esophagus Squamous cell carcinoma 2 III T3N1M0 Malignant
E5 53 M 53 Esophagus Squamous cell carcinoma 2 IIa T3N0M0 Malignant
E6 54 F 63 Esophagus Squamous cell carcinoma 2 IIa T2N0M0 Malignant
E7 55 M 46 Esophagus Squamous cell carcinoma 2 IIa T3N0M0 Malignant
E8 56 M 76 Esophagus Squamous cell carcinoma 2 III T3N1M0 Malignant
E9 57 M 49 Esophagus Squamous cell carcinoma 2 IIa T2N0M0 Malignant
E10 58 M 65 Esophagus Squamous cell carcinoma 2 IIa T3N0M0 Malignant
E11 59 M 44 Esophagus Squamous cell carcinoma 3 III T3N1M0 Malignant
E12 60 M 53 Esophagus Squamous cell carcinoma 3 IIa T3N0M0 Malignant
F1 61 M 60 Esophagus Squamous cell carcinoma 2 IIa T3N0M0 Malignant
F2 62 M 59 Esophagus Squamous cell carcinoma 2 IIa T3N0M0 Malignant
F3 63 F 47 Esophagus Squamous cell carcinoma 2 IIa T3N0M0 Malignant
F4 64 M 60 Esophagus Squamous cell carcinoma 2 III T3N1M0 Malignant
F5 65 M 53 Esophagus Squamous cell carcinoma 2 IIa T3N0M0 Malignant
F6 66 F 63 Esophagus Squamous cell carcinoma 2 IIa T2N0M0 Malignant
F7 67 M 46 Esophagus Squamous cell carcinoma 2 IIa T3N0M0 Malignant
F8 68 M 76 Esophagus Squamous cell carcinoma 2 III T3N1M0 Malignant
F9 69 M 49 Esophagus Squamous cell carcinoma 2 IIa T2N0M0 Malignant
F10 70 M 65 Esophagus Squamous cell carcinoma 2 IIa T3N0M0 Malignant
F11 71 M 44 Esophagus Squamous cell carcinoma 3 III T3N1M0 Malignant
F12 72 M 53 Esophagus Squamous cell carcinoma 3 IIa T3N0M0 Malignant
G1 73 M 40 Esophagus Carcinoma in-situ – 0 TisN0M0 In-situ
G2 74 F 69 Esophagus Carcinoma in-situ – 0 TisN0M0 In-situ
G3 75 M 66 Esophagus Chronic inflammation – – – Inflammation
G4 76 F 63 Esophagus Mild-moderate atypical hyperplasia – – – Hyperplasia
G5 77 M 44 Esophagus Chronic inflammation of mucous membrane – – – Inflammation
G6 78 M 66 Esophagus Chronic inflammation of mucous membrane – – – Inflammation
G7 79 M 44 Esophagus Chronic inflammation of mucous membrane – – – Inflammation
G8 80 F 60 Esophagus Chronic inflammation of mucous membrane – – – Inflammation
G9 81 F 18 Esophagus Normal esophagus tissue – – – Normal
G10 82 F 19 Esophagus Normal esophagus tissue – – – Normal
G11 83 F 40 Esophagus Normal esophagus tissue (sparse) – – – Normal
G12 84 F 41 Esophagus Normal esophagus tissue (sparse) – – – Normal
H1 85 M 40 Esophagus Carcinoma in situ (mucous and gland) – 0 TisN0M0 In-situ
H2 86 F 69 Esophagus Carcinoma in situ (chronic inflammation of smooth muscle and fibrous tissue) – 0 TisN0M0 In-situ
H3 87 M 66 Esophagus Chronic inflammation – – – Inflammation
H4 88 F 63 Esophagus Mild-moderate atypical hyperplasia – – – Hyperplasia
H5 89 M 44 Esophagus Chronic inflammation of mucous membrane – – – Inflammation
H6 90 M 66 Esophagus Chronic inflammation of mucous membrane – – – Inflammation
H7 91 M 44 Esophagus Chronic inflammation of mucous membrane (mucous gland) – – – Inflammation
H8 92 F 60 Esophagus Chronic inflammation of mucous membrane (sparse) – – – Inflammation
H9 93 F 18 Esophagus Normal esophagus tissue – – – Normal
H10 94 F 19 Esophagus Normal esophagus tissue – – – Normal
H11 95 F 40 Esophagus Normal esophagus tissue (fibrous tissue and skeletal muscle) – – – Normal
H12 96 F 41 Esophagus Normal esophagus tissue – – Normal
– – M 42 Adrenal gland Pheochromocytoma (tissue marker) – Malignant

† For precise diagnosis, refer to pathology description.

**The grade 1-3 (or I-III) in Pathology Diagnosis is equivalent to well-differentiated, moderately-differentiated or poorly differentiated, respectively, under microscope.
Grade 1 or well-differentiated: Cells appear normal and are not growing rapidly.
Grade 2 or moderately-differentiated: Cells appear slightly different than normal.
Grade 3 or poorly differentiated: Cells appear abnormal and tend to grow and spread more aggressively.
Grade 4 or undifferentiated: *(for certain tumors), features are not significantly distinguishing to make it look any different from undifferentiated cancers which occur in other organs.

TNM grading:

T - Primary tumor
Tx - Primary tumor cannot be assessed
T0 - No evidence of primary tumor
Tis - Carcinoma in situ; intraepithelial or invasion of lamina propria
T1 - Tumor invades submucosa
T2 - Tumor invades muscularis propria
T3 - Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
T4 - Tumor directly invades other organs or structures and/or perforate visceral peritoneum

N - Regional lymph nodes
Nx - Regional lymph nodes cannot be assessed
N0 - No regional lymph node metastasis
N1 - Metastasis in 1 to 3 regional lymph nodes
N2 - Metastasis in 4 or more regional lymph nodes

M - Distant metastasis
Mx - Distant metastasis cannot be assessed
M0 - No distant metastasis
M1 - Distant metastasis

Find overlapping cases with this tissue array:
© 2003 - 2011 US Biomax Inc., custsrv@biomax.us, Tel: (800) 935-1357 | Privacy Policy

Authorize.Net Seal Starfield Seal